|
Re: Yet another potential indication: Reduction of drug-seeking behavior
|
4
|
Resverlogix Corp.
|
Oct 26, 2021 06:44PM
|
|
Re: ZEN003694 Trial Now Listed on ClinicalTrials.gov
|
4
|
Zenith Epigenetics
|
Mar 10, 2016 03:49PM
|
|
Re: New research report 5/11/16 by Marcel Wijma, Van Leeuwenhoeck Institute
|
4
|
Resverlogix Corp.
|
May 15, 2016 05:04PM
|
|
Re: Zenith AGM
|
4
|
Zenith Epigenetics
|
Nov 22, 2023 06:20PM
|
|
Re: Just back from IR,...
|
4
|
Resverlogix Corp.
|
Oct 29, 2019 02:49PM
|
|
Re: RVX announces first right of refusal for license deal in the US
|
4
|
Resverlogix Corp.
|
Oct 24, 2017 01:10PM
|
|
rvx-208 Australian trial
|
4
|
Resverlogix Corp.
|
May 24, 2015 03:14PM
|
|
Re: Wow! Quite the read!
|
4
|
Resverlogix Corp.
|
May 30, 2021 06:35PM
|
|
Re: Great Presetation today
|
4
|
Zenith Epigenetics
|
Oct 24, 2017 01:39PM
|
|
Re: Great Discussion
|
4
|
Resverlogix Corp.
|
Oct 19, 2017 12:21PM
|
|
Re: Some back of the envelope calculations.....
|
4
|
Resverlogix Corp.
|
Jun 20, 2015 11:05AM
|
|
Re: New Publication
|
4
|
Resverlogix Corp.
|
Feb 28, 2023 06:17PM
|
|
Re: here's one of the newswires
|
4
|
Resverlogix Corp.
|
Jan 12, 2018 11:43AM
|
|
Re: Long Covid
|
4
|
Resverlogix Corp.
|
Jan 22, 2024 01:42PM
|
|
Re: RESVERLOGIX ANNOUNCES VOTING RESULTS FROM THE 2022 MEETING OF SHAREHOLDERS
|
4
|
Resverlogix Corp.
|
Jun 27, 2022 07:35PM
|
|
Re: Thoughts?
|
4
|
Resverlogix Corp.
|
Apr 07, 2021 10:26AM
|
|
Re: Apabetalone’s Positive Impact on COVID-19 in Human Lung Cells Published in Biomedicines
|
4
|
Resverlogix Corp.
|
Apr 21, 2021 11:25AM
|
|
Re: Covid
|
4
|
Resverlogix Corp.
|
Aug 12, 2022 05:36PM
|
|
Re: Conspiracies of sorts
|
4
|
Resverlogix Corp.
|
Sep 28, 2015 10:52AM
|
|
Re: Zenith Epigenetics Announces U.S. FDA Clearance of Investigational New Drug Application for ZEN-3694 in TNBC Program
|
4
|
Zenith Epigenetics
|
Mar 20, 2019 04:50PM
|
